
The unpredictable temperatures of changing seasons often bring out aches and pains for many of us, but for 2.1 million people in the United States with rheumatoid arthritis, those pains often continue throughout the year.
The latest articles related to Dmards rheumatoid arthritis

Up until the mid 1990’s the best we, as rheumatologists could do with patients with rheumatoid arthritis (RA), was to relieve their pain, suppress their disease a bit, and maybe slow it down some.
With the advent of biologic therapies, specifically tumor necrosis inhibitors (anti-TNF drugs), it is now possible to get the disease into complete remission. And, it is not out of the realm of possibility that if treated early enough and aggressively enough, some patients with R…

Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune inflammatory disease that affects more than 2 million Americans.It is the subject of intense interest since it is so common and the lessons learned from it may help in the management of other forms of inflammatory arthritis.Currently, the initial step upon diagnosis…

Prior to the development of newer biologic medications, rheumatologists were relegated to using disease modifying anti-rheumatic drugs (DMARDS) to treat rheumatoid arthritis (RA).These DMARDS (drugs such as methotrexate, hydroxychloroquine [Plaquenil], sulfasalazine [Azulfidine]), were and continue to be helpful in reducing signs and symptoms of disease but do not have the…